Rules Based Medicine (RBM; Austin, TX), a biomarker testing laboratory, announced today the launch of CardiovascularMAP.
Based on RBM’s proprietary Multi-Analyte Profiling (MAP) platform, CardiovascularMAP is designed to advance the development of drugs for cardiovascular disease. Pharmaceutical and biotechnology groups collaborated to design the tool, which combines common biomarkers with additional ones to identify new patterns of disease.
"RBM is providing access to the most comprehensive array of cardiovascular biomarkers ever
assembled in one panel,” said George P. Rodgers, MD, FACC, past chairman of the
American College of Cardiology Board of Governors, in a press release. “Accurate measurement of these
biomarkers clearly has the potential to accelerate CVD research programs."
For more information, click here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.